Dose Escalation Study of TriN2755 in Advanced Solid Tumors and Sarcomas

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01259518
Recruitment Status : Unknown
Verified June 2011 by Trin Therapeutics GmbH.
Recruitment status was:  Recruiting
First Posted : December 14, 2010
Last Update Posted : June 8, 2011
University Hospital, Essen
Central European Society for Anticancer Drug Research
Assign Data Management and Biostatistics GmbH
Information provided by:
Trin Therapeutics GmbH

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : September 2011
  Estimated Study Completion Date : January 2012